A case of drug-induced hypersensitivity syndrome showing transient immunosuppression before viral reactivation during treatment for pemphigus foliaceus

Clinical and Experimental Dermatology

Volumn 31, Issue 1, 2006, Pages 33-35

  Takahashi, H ^a   Tanaka, M ^a   Tanikawa, A ^a   Toyohara, A ^b   Ogo, Y ^c   Morimoto, A ^a   Harato, R ^a   Kobayashi, M ^a   Amagai, M ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO INSTITUTE HOSPITAL   (Japan)

^c OGO Skin Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DAPSONE; DESMOGLEIN 1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; BLOOD; CASE REPORT; CYTOMEGALOVIRUS; DRUG HYPERSENSITIVITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOLOGY; LYMPHOCYTE COUNT; MALE; ORAL DRUG ADMINISTRATION; PEMPHIGUS; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION;

ADMINISTRATION, ORAL; ADULT; ANTI-INFECTIVE AGENTS; CYTOMEGALOVIRUS; DAPSONE; DESMOGLEIN 1; DRUG HYPERSENSITIVITY; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTE COUNT; MALE; PEMPHIGUS; VIRUS ACTIVATION;

EID: 33646082274     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01913.x     Document Type: Article

References (12)

1. Tohyama M, Yahata Y, Yasukawa M et al. Severe hyper-sensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998; 134: 1113-17.
2. Suzuki Y, Inagi R, Aono T et al. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998; 134: 1108-12.
3. Dockrell DH, Paya CV. Human herpesvirus-6 and-7 in transplantation. Rev Med Virol 2001; 11: 23-36.
4. Ljungman P. Beta-herpesvirus challenges in the transplant recipient. J Infect Dis 2002; 186 (Suppl. 1): S99-109.
5. Yoshikawa T. Human herpesvirus-6 and-7 infections in transplantation. Pediatr Transplant 2003; 7: 11-17.
6. Wang FZ, Dahl H, Linde A et al. Lymphotropic herpesvi-ruses in allogeneic bone marrow transplantation. Blood 1996; 88: 3615-20.
7. Aihara Y, Ito SI, Kobayashi Y et al. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol 2003; 149: 165-9.
8. Fujino Y, Nakajima M, Inoue H et al. Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome. Ann Neurol 2002; 51: 771-4.
9. Masaki T, Fukunaga A, Tohyama M et al. Human herpes virus 6 encephalitis in allopurinol-induced hypersensitivity syndrome. Acta Derm Venereol 2003; 83: 128-31.
10. Ljungman P. Prevention and treatment of viral infections in stem cell transplant recipients. Br J Haematol 2002; 118: 44-57.
11. Khanna KM, Bonneau RH, Kinchington PR et al. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 2003; 18: 593-603.
12. Kunisaki Y, Goto H, Kitagawa K et al. Salazosulfapyridine induced hypersensitivity syndrome associated with reactivation of humanherpes virus 6. Intern Med 2003; 42: 203-7.